Category: NASDAQ News

Precipio (NASDAQ: PRPO) Signs First Major International Services Contract

Contract expected to generate over $1.5M in revenues annually NEW HAVEN, Conn., April 29, 2019 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) today announced that it has signed a services contract with a health care management group serving several major hospitals based in Cairo, Egypt. Precipio is engaged to provide both expert pathology […]

Continue Reading

New Age (NASDAQ: NBEV) Launches CBD Globally

DENVER, CO / ACCESSWIRE / April 25, 2019 / NEW AGE BEVERAGES CORPORATION (NASDAQ:NBEV), the Colorado and Utah-based organic and natural beverage company intending to become the world’s leading healthy beverages and lifestyles company, today announced the global launch of their CBD product portfolio, with the unveiling of their line and shipment of their CBD […]

Continue Reading

VERB Announces Closing of Sound Concepts Acquisition

HOLLYWOOD, Calif., April 17, 2019 (GLOBE NEWSWIRE) — VERB Technology Company, Inc.(NASDAQ: VERB) (“VERB”), a leader in business-focused interactive video, and the pioneer of Augmented Sales Intelligence software, announces that it has completed its previously announced acquisition of Sound Concepts (the “Closing”), the leading provider of sales and marketing tools and digital technology solutions in the […]

Continue Reading

Beyond Commerce (OTCQB: BYOC) Submits Application to List on NASDAQ

LAS VEGAS, NV / ACCESSWIRE / April 16, 2019 / Beyond Commerce, Inc. (OTCQB: BYOC) (the ”Company”), a global provider of B2B internet marketing analytics, technologies and services, is pleased to announce that the Company has submitted its application to list its common shares on the NASDAQ Capital Market (”NASDAQ”). ”Elevating the listing of our common stock […]

Continue Reading

Bellerophon (NASDAQ : BLPH) Announces Agreement with FDA on Regulatory Approval Pathway for INOpulse® for Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease

GlobeNewswire – Press Releases Posted 08-Apr-2019 at 08:30 am EST FDA Agrees to Primary Endpoint of Change in Moderate to Vigorous Physical Activity from Baseline to Week 16, Measured by Actigraphy FDA Also Agrees on Modification of Ongoing Phase 2b Study into a Phase 2/3 Trial, with Cohort 3 Serving as the Pivotal Phase 3 […]

Continue Reading

New Age Beverages (NASDAQ: NBEV) announced distribution expansion of Marley brand with Walmart

April 8, 2019 6:34 AM New Age Beverages Corporation (NASDAQ: NBEV), the Colorado and Utah-based organic and natural beverage company intending to become the world’s leading healthy beverages and lifestyles company, today announced the distribution expansion of their Marley brand with Walmart (NYSE: WMT), the world’s largest retailer. KEY HIGHLIGHTS: First national account penetration for New Age […]

Continue Reading

Histogenics (Nasdaq: HSGX) and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics

BOSTON, Mass. and MALVERN, Penn., April 08, 2019 (GLOBE NEWSWIRE) — Histogenics Corporation (Nasdaq: HSGX) and Ocugen, Inc., a privately held clinical-stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases, today jointly announced that they have entered into a definitive merger agreement under […]

Continue Reading

Shineco, Inc. (NASDAQ: TYHT) Enters into Strategic Cooperation Agreement with Regional People’s Government for Construction of Industrial Hemp Planting Base

BEIJING, April 4, 2019 /PRNewswire/ — Shineco, Inc. (“Shineco” or the “Company”;NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and various health and well-being focused plant-based products in China, announced today that the Company, through its wholly owned subsidiary Tenjove NewHemp Biotech Co., Ltd. (“TNB”), entered into a strategic cooperation agreement (the “Agreement”) with […]

Continue Reading

SANGAMO AND PFIZER ANNOUNCE PHASE 1/2 INTERIM DATA FOR INVESTIGATIONAL HEMOPHILIA A GENE THERAPY

EIGHT PATIENTS TREATED WITH SB-525 GENE THERAPY SHOWED DOSE-DEPENDENT INCREASES IN FVIII ACTIVITY, WITH THE TWO PATIENTS TREATED WITH THE 3E13 VG/KG DOSE REACHING NORMAL FVIII LEVELS SAFETY MONITORING COMMITTEE RECOMMENDED EXPANSION OF THE 3E13 VG/KG DOSE COHORT Tuesday, April 2, 2019 – 7:00am EDT BRISBANE, Calif. & Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic […]

Continue Reading

ADMA Boologics (NASDAQ: ADMA) Announces FDA Approves ASCENIV™, a Novel Intravenous Immune Globulin

Approved for Use in the Treatment of Primary Humoral Immunodeficiency Disease (“PIDD” or “PI”) in Adults and Adolescents (12 to 17 Years of Age) FDA Approval Triggers Funding up to $27.5M from Existing Credit Facility with Perceptive Advisors RAMSEY, N.J. and BOCA RATON, Fla., April 01, 2019 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (NASDAQ: ADMA) […]

Continue Reading

Facebook